Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$7.56M
14.08K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 14.08K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $7.56M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2026ACC: 0001950047-26-009360
DirectorOfficer· President and CEO
Since Mar 2026
14.08K
Shares to sell
$7.56M
Approx. market value
5.22K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
9/8/2025
5.22KTotal acquired5.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2025 | Restricted Stock Units N/A | 5.22K | — |
| Total | 5.22K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6.36K
Market value
$3.41M
9/9/2026
—Completed
Units to sell
2.50K
Market value
$1.37M
7/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.22K
Market value
$2.78M
9/11/2026
Total
Units
14.08K
Value
$7.56M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/9/2026 | 6.36K | $3.41M | — | Completed |
7/20/2026 | 2.50K | $1.37M | — | Completed |
| Planned — Approximate Date | ||||
9/11/2026 | 5.22K | $2.78M | NASDAQ | Planned |
| Total | 14.08K | $7.56M | ||